Saudi Arabia Blood Bags Market, By Product Type (Single Blood Bag, Double Blood Bag, Triple Blood Bag, Quadruple Blood Bag, Penta Blood Bag), By Type (Collection Bag, Transfer Bag), By Volume (100ml, 150ml, 250ml, 300ml, 350ml, 400ml, 450ml, 500ml), By Material (PVC, PET, Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centre, Blood Banks, Others) By Region, Competition, Forecast & Opportunities, 2020-2030F
Market Overview
The Saudi Arabia Blood Bags Market was valued at USD 11.74 million in 2024 and is projected to reach USD 16.02 million by 2030, growing at a CAGR of 5.28% during the forecast period. This market serves as an integral part of the Kingdom’s healthcare system, addressing the critical need for reliable and safe blood collection, storage, and transfusion solutions.
Market growth is being fueled by healthcare investments under the Vision 2030 initiative, increased surgical volumes, and a rise in chronic hematologic conditions. The growing prevalence of maternal health complications and expansion of national health initiatives are also contributing to the increased demand for blood and its components. Advanced blood bag systems are becoming essential to meet these evolving clinical and operational requirements, supporting the market’s upward trajectory.
Key Market Drivers
Increasing Prevalence of Hematologic and Genetic Blood Disorders
The rising burden of blood-related conditions—both inherited and acquired—is a primary driver of demand for blood bags in Saudi Arabia. Diseases such as leukemia, lymphoma, and multiple myeloma, as reported by the Global Cancer Observatory in 2020, are significantly increasing the need for transfusions.
Furthermore, the Kingdom sees a high prevalence of genetic disorders like thalassemia and sickle cell anemia, particularly in the Eastern Province, where carrier and disease rates are among the highest nationally.
4.2% of the population carries the sickle cell trait
0.26% are affected by sickle cell disease
Thalassemia patients often require monthly transfusions
This ongoing clinical need has led to a consistent demand for triple and quadruple blood bags, which allow efficient separation of components like red cells, platelets, and plasma, enabling precision in transfusion protocols.
Key Market Challenges
Import Dependence and Supply Chain Vulnerabilities
Saudi Arabia’s reliance on imported blood bags creates vulnerabilities tied to global supply chain disruptions. Delays in logistics, geopolitical uncertainties, and raw material shortages can interrupt supply, while customs regulations and currency volatility increase procurement complexity and cost.
Although the Vision 2030 agenda emphasizes domestic manufacturing, local production of advanced multi-compartment blood bags remains underdeveloped. This limited local capacity restricts adaptability during periods of elevated demand or global instability, making it challenging to ensure continuous and responsive supply across all regions.
Key Market Trends
Shift Toward Blood Component Therapy and Precision Transfusion
A significant trend shaping the Saudi market is the growing adoption of blood component therapy over whole blood transfusions. This targeted approach enhances clinical outcomes by delivering only the required blood components—such as red blood cells, platelets, or plasma—to patients based on specific medical needs.
This shift is driving increased procurement of triple, quadruple, and penta blood bags that support efficient component separation and storage. As healthcare facilities modernize and adopt more specialized transfusion protocols, demand is shifting toward advanced blood bag systems that offer superior sterility, durability, and traceability, aligning with global best practices in transfusion medicine.
Key Market Players
In this report, the Saudi Arabia Blood Bags Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Saudi Arabia Blood Bags Market.
Available Customizations:
Saudi Arabia Blood Bags market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
The Saudi Arabia Blood Bags Market was valued at USD 11.74 million in 2024 and is projected to reach USD 16.02 million by 2030, growing at a CAGR of 5.28% during the forecast period. This market serves as an integral part of the Kingdom’s healthcare system, addressing the critical need for reliable and safe blood collection, storage, and transfusion solutions.
Market growth is being fueled by healthcare investments under the Vision 2030 initiative, increased surgical volumes, and a rise in chronic hematologic conditions. The growing prevalence of maternal health complications and expansion of national health initiatives are also contributing to the increased demand for blood and its components. Advanced blood bag systems are becoming essential to meet these evolving clinical and operational requirements, supporting the market’s upward trajectory.
Key Market Drivers
Increasing Prevalence of Hematologic and Genetic Blood Disorders
The rising burden of blood-related conditions—both inherited and acquired—is a primary driver of demand for blood bags in Saudi Arabia. Diseases such as leukemia, lymphoma, and multiple myeloma, as reported by the Global Cancer Observatory in 2020, are significantly increasing the need for transfusions.
Furthermore, the Kingdom sees a high prevalence of genetic disorders like thalassemia and sickle cell anemia, particularly in the Eastern Province, where carrier and disease rates are among the highest nationally.
4.2% of the population carries the sickle cell trait
0.26% are affected by sickle cell disease
Thalassemia patients often require monthly transfusions
This ongoing clinical need has led to a consistent demand for triple and quadruple blood bags, which allow efficient separation of components like red cells, platelets, and plasma, enabling precision in transfusion protocols.
Key Market Challenges
Import Dependence and Supply Chain Vulnerabilities
Saudi Arabia’s reliance on imported blood bags creates vulnerabilities tied to global supply chain disruptions. Delays in logistics, geopolitical uncertainties, and raw material shortages can interrupt supply, while customs regulations and currency volatility increase procurement complexity and cost.
Although the Vision 2030 agenda emphasizes domestic manufacturing, local production of advanced multi-compartment blood bags remains underdeveloped. This limited local capacity restricts adaptability during periods of elevated demand or global instability, making it challenging to ensure continuous and responsive supply across all regions.
Key Market Trends
Shift Toward Blood Component Therapy and Precision Transfusion
A significant trend shaping the Saudi market is the growing adoption of blood component therapy over whole blood transfusions. This targeted approach enhances clinical outcomes by delivering only the required blood components—such as red blood cells, platelets, or plasma—to patients based on specific medical needs.
This shift is driving increased procurement of triple, quadruple, and penta blood bags that support efficient component separation and storage. As healthcare facilities modernize and adopt more specialized transfusion protocols, demand is shifting toward advanced blood bag systems that offer superior sterility, durability, and traceability, aligning with global best practices in transfusion medicine.
Key Market Players
- Terumo Middle East
- Fresenius Kabi
- Madac International for Medical Products Factory
- RENOLIT
- Abdulla Fouad Group
- Kiefel Technologies
- AdvaCare Pharma
- Jamjoom Group
In this report, the Saudi Arabia Blood Bags Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Saudi Arabia Blood Bags Market, By Product Type:
- Single Blood Bag
- Double Blood Bag
- Triple Blood Bag
- Quadruple Blood Bag
- Penta Blood Bag
- Saudi Arabia Blood Bags Market, By Type:
- Collection Bag
- Transfer Bag
- Saudi Arabia Blood Bags Market, By Volume:
- 100ml
- 150ml
- 250ml
- 300ml
- 350ml
- 400ml
- 450ml
- 500ml
- Saudi Arabia Blood Bags Market, By Material:
- PVC
- PET
- Others
- Saudi Arabia Blood Bags Market, By End User:
- Hospitals & Clinics
- Ambulatory Surgical Centre
- Blood Banks
- Others
- Saudi Arabia Blood Bags Market, By Region:
- Northern & Central
- Southern
- Eastern
- Western
Company Profiles: Detailed analysis of the major companies present in the Saudi Arabia Blood Bags Market.
Available Customizations:
Saudi Arabia Blood Bags market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. PRODUCT OVERVIEW
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. SAUDI ARABIA BLOOD BAGS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Single Blood Bag, Double Blood Bag, Triple Blood Bag, Quadruple Blood Bag, Penta Blood Bag)
5.2.2. By Type (Collection Bag, Transfer Bag)
5.2.3. By Volume (100ml, 150ml, 250ml, 300ml, 350ml, 400ml, 450ml, 500ml)
5.2.4. By Material (PVC, PET, Others)
5.2.5. By End User (Hospitals & Clinics, Ambulatory Surgical Centre, Blood Banks, Others)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. NORTHERN & CENTRAL SAUDI ARABIA BLOOD BAGS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Type
6.2.3. By Volume
6.2.4. By Material
6.2.5. By End User
7. SOUTHERN SAUDI ARABIA BLOOD BAGS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Type
7.2.3. By Volume
7.2.4. By Material
7.2.5. By End User
8. EASTERN SAUDI ARABIA BLOOD BAGS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Type
8.2.3. By Volume
8.2.4. By Material
8.2.5. By End User
9. WESTERN SAUDI ARABIA BLOOD BAGS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Type
9.2.3. By Volume
9.2.4. By Material
9.2.5. By End User
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12. SAUDI ARABIA BLOOD BAGS MARKET: SWOT ANALYSIS
13. COMPETITIVE LANDSCAPE
13.1. Terumo Middle East
13.1.1. Business Overview
13.1.2. Product & Service Offerings
13.1.3. Recent Developments
13.1.4. Key Personnel
13.1.5. Financials (If Listed)
13.1.6. SWOT Analysis
13.2. Fresenius Kabi
13.3. Madac International for Medical Products Factory
13.4. RENOLIT
13.5. Abdulla Fouad Group
13.6. Kiefel Technologies
13.7. AdvaCare Pharma
13.8. Jamjoom Group
14. STRATEGIC RECOMMENDATIONS
15. ABOUT US & DISCLAIMER
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. RESEARCH METHODOLOGY
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. EXECUTIVE SUMMARY
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. VOICE OF CUSTOMER
5. SAUDI ARABIA BLOOD BAGS MARKET OUTLOOK
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product Type (Single Blood Bag, Double Blood Bag, Triple Blood Bag, Quadruple Blood Bag, Penta Blood Bag)
5.2.2. By Type (Collection Bag, Transfer Bag)
5.2.3. By Volume (100ml, 150ml, 250ml, 300ml, 350ml, 400ml, 450ml, 500ml)
5.2.4. By Material (PVC, PET, Others)
5.2.5. By End User (Hospitals & Clinics, Ambulatory Surgical Centre, Blood Banks, Others)
5.2.6. By Region
5.2.7. By Company (2024)
5.3. Market Map
6. NORTHERN & CENTRAL SAUDI ARABIA BLOOD BAGS MARKET OUTLOOK
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product Type
6.2.2. By Type
6.2.3. By Volume
6.2.4. By Material
6.2.5. By End User
7. SOUTHERN SAUDI ARABIA BLOOD BAGS MARKET OUTLOOK
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product Type
7.2.2. By Type
7.2.3. By Volume
7.2.4. By Material
7.2.5. By End User
8. EASTERN SAUDI ARABIA BLOOD BAGS MARKET OUTLOOK
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product Type
8.2.2. By Type
8.2.3. By Volume
8.2.4. By Material
8.2.5. By End User
9. WESTERN SAUDI ARABIA BLOOD BAGS MARKET OUTLOOK
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product Type
9.2.2. By Type
9.2.3. By Volume
9.2.4. By Material
9.2.5. By End User
10. MARKET DYNAMICS
10.1. Drivers
10.2. Challenges
11. MARKET TRENDS & DEVELOPMENTS
11.1. Recent Developments
11.2. Product Launches
11.3. Mergers & Acquisitions
12. SAUDI ARABIA BLOOD BAGS MARKET: SWOT ANALYSIS
13. COMPETITIVE LANDSCAPE
13.1. Terumo Middle East
13.1.1. Business Overview
13.1.2. Product & Service Offerings
13.1.3. Recent Developments
13.1.4. Key Personnel
13.1.5. Financials (If Listed)
13.1.6. SWOT Analysis
13.2. Fresenius Kabi
13.3. Madac International for Medical Products Factory
13.4. RENOLIT
13.5. Abdulla Fouad Group
13.6. Kiefel Technologies
13.7. AdvaCare Pharma
13.8. Jamjoom Group
14. STRATEGIC RECOMMENDATIONS
15. ABOUT US & DISCLAIMER
